The rating assignment was based on a number of factors, including NYP’s large clinical footprint, solid market position and sizeable revenue base, according to Fitch. The rating assignment was also supported by the benefits of NYP being part of the larger non-obligated NYP Health System, as well as supporting organizations.
Fitch believes NYP and NYPHS are in a good position to handle the competitive New York healthcare market. However, “failure to sustain current levels of operational performance, liquidity and capital spending could result in downward rating pressure,” according to Fitch.
More articles on healthcare finance:
Board of Texas Children’s Hospital approves $506M expansion
Moody’s assigns ‘A2’ ratings to MedStar Health’s bonds
HCA’s $1B deal is good news for junk bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
